Delirious mania: detection, diagnosis, and clinical management in the acute setting.
Jacobowski NL, Heckers S, Bobo WV.
J Psychiatr Pract. 2013 Jan;19(1):15-28. doi: 10.1097/01.pra.0000426324.67322.06.
Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.
Doyno CR, White CM.
J Clin Pharmacol. 2021 Aug;61 Suppl 2:S114-S128. doi: 10.1002/jcph.1922.
Doxefazepam.
[No authors listed]
IARC Monogr Eval Carcinog Risks Hum. 1996;66:97-104.
Sedative, antiepileptic and antipsychotic effects of Viscum album L. (Loranthaceae) in mice and rats.
Gupta G, Kazmi I, Afzal M, Rahman M, Saleem S, Ashraf MS, Khusroo MJ, Nazeer K, Ahmed S, Mujeeb M, Ahmed Z, Anwar F.
J Ethnopharmacol. 2012 Jun 14;141(3):810-6. doi: 10.1016/j.jep.2012.03.013. Epub 2012 Mar 18.
Sedative-hypnotic, anxiolytic and possible side effects of Salvia limbata C. A. Mey. Extracts and the effects of phenological stage and altitude on the rosmarinic acid content.
Jahani R, Behzad S, Saffariha M, Toufan Tabrizi N, Faizi M.
J Ethnopharmacol. 2022 Jan 10;282:114630. doi: 10.1016/j.jep.2021.114630. Epub 2021 Sep 10.
Hypnotic and antiepileptic effects of cannabidiol.
Carlini EA, Cunha JM.
J Clin Pharmacol. 1981 Aug-Sep;21(S1):417S-427S. doi: 10.1002/j.1552-4604.1981.tb02622.x.
Recommended dosages of analgesic and sedative drugs in intensive care result in a low incidence of potentially toxic blood concentrations.
Lennborn U, Johansson A, Lindgren E, Nielsen EI, Sandler H, Bertilsson M, Kronstrand R, Ahlner J, Kugelberg FC, Rubertsson S.
Ups J Med Sci. 2024 May 9;129. doi: 10.48101/ujms.v129.10560. eCollection 2024.
Acute Methylenedioxypyrovalerone Toxicity.
Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE; ACMT Toxicology Investigators Consortium (ToxIC).
J Med Toxicol. 2015 Jun;11(2):185-94. doi: 10.1007/s13181-014-0446-8.
Iatrogenic neurology.
Sposato LA, Fustinoni O.
Handb Clin Neurol. 2014;121:1635-71. doi: 10.1016/B978-0-7020-4088-7.00107-3.
Removal of sedative-hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy.
Theodore WH, Porter RJ.
Ann Neurol. 1983 Mar;13(3):320-4. doi: 10.1002/ana.410130316.
